Pharmaniaga Mefenamic Dosage & Drug Information

Concise Prescribing Info

Contents

Mefenamic acid

Indications/Uses

Mild to moderate pain, rheumatic disorders, dysmenorrhoea, menorrhagia.

Dosage/Direction for Use

Adult Initially 500 mg, then 250 mg 6 hrly, not exceeding 1 wk.

Administration

Should be taken with food: Take immediately after meals.

Contraindications

Peptic ulceration, inflammatory bowel disease.

Special Precautions

Renal or hepatic impairment. Elderly.

Adverse Reactions

GI disturbances, bleeding peptic ulceration, headache, drowsiness, dizziness, nervousness, visual disturbances, skin rashes, urticaria, haemolytic anaemia agranulocytosis, pancytopenia, thrombocytopenia.

View ADR Monitoring Form

Drug Interactions

Coumarin anticoagulants, lithium, MTX, glycosides, phenytoin, sulphonylureas, antihypertensives.

MIMS Class

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

ATC Classification

M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, fenamates.

Regulatory Classification

Presentation/Packing

Form

Pharmaniaga Mefenamic cap 250 mg

Packing/Price

50 × 10's

Form

Pharmaniaga Mefenamic FC tab 500 mg

Packing/Price

50 × 10's

Pharmaniaga Mefenamic

mefenamic acid

Manufacturer:

Pharmaniaga Manufacturing Berhad

Distributor:

Pharmaniaga Logistics